Botros S S, Salama S H, Estafan M Y, Gomaa N E, Metwally A A, Ebeid F A
Pharmacology Department, Theodor Bilharz Research Institute, Imbaba, Giza, Egypt.
Pharmacol Res. 1990 May-Jun;22(3):359-70. doi: 10.1016/1043-6618(90)90734-u.
The schistosomicidal efficacy of praziquantel (2 x 500 mg/kg), oxamniquine (1 x 100 mg/kg) and combined one-third the curative dose of each of them (333 mg/kg praziquantel + 33 mg/kg oxamniquine), were correlated to gonadal steroid hormonal changes and state of disease immunopathology, in mice infected with 100 Schistosoma mansoni (S. mansoni) cercariae. Maximum efficacy recorded with combination regimen particularly 4 weeks after treatment, was accompanied by maximum reduction in granuloma volume (65%), least fall in testosterone level (-56.2 and -60.2% in male and female mice respectively) and increased progesterone level (+33.9 and +81.5% in male and female mice respectively). These findings revealed a potentiated effect of combination therapy on mature infection and the possible involvement of gonadal steroid hormones in affecting the efficacy of schistosomicidal drugs and state of disease immunopathology.
在感染100条曼氏血吸虫尾蚴的小鼠中,研究了吡喹酮(2×500毫克/千克)、奥沙尼喹(1×100毫克/千克)以及二者各三分之一治疗剂量的组合(333毫克/千克吡喹酮 + 33毫克/千克奥沙尼喹)的杀血吸虫效果,并将其与性腺甾体激素变化及疾病免疫病理学状态相关联。联合用药方案记录到的最大疗效,尤其是在治疗后4周,伴随着肉芽肿体积最大程度的减小(65%)、睾酮水平下降最少(雄性和雌性小鼠分别下降56.2%和60.2%)以及孕酮水平升高(雄性和雌性小鼠分别升高33.9%和81.5%)。这些发现揭示了联合疗法对成熟感染的增效作用,以及性腺甾体激素可能参与影响杀血吸虫药物的疗效和疾病免疫病理学状态。